Evidence map›Paper›PMID 41164403›Full record

ArticleDrug design, development and therapy2025

Optimizing Micafungin Dosing in Patients with Critically Ill Candidemia and Trends of

Jutharat Watcharasuwanseree, Worawong Chueansuwan, Nuntra Suwantarat, Wichai Santimaleeworagun, Piraporn Juntanawiwat, Adisak Sangchankoom, Weerayuth Saelim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jutharat WatcharasuwansereeThe College of Pharmacotherapy of Thailand, Nonthaburi, Thailand.
Worawong ChueansuwanDivision of Infectious Diseases, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Nuntra SuwantaratDivision of Infectious Diseases, Department of Internal Medicine, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.ORCID 0000-0002-9356-2592
Wichai SantimaleeworagunDivision of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.
Piraporn JuntanawiwatDepartment of Clinical Pathology, Division of Microbiology, Phramongkutklao Hospital, Bangkok, Thailand.
Adisak SangchankoomDivision of Microbiology, Clinical Laboratory, Udonthani Hospital, Udonthani, Thailand.
Weerayuth SaelimDivision of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.ORCID 0000-0001-5839-440X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to determine the optimal micafungin dosage for treating candidemia in critically ill adult patients using Monte Carlo simulation. Patients and Methods: Clinical Results: In total, 128 clinical Conclusion: Non-

Indexed as

Antifungal AgentsCandidaCandidemiaMicafunginAdultCritical IllnessDose-Response Relationship, DrugHumansMicrobial Sensitivity TestsMonte Carlo MethodTertiary Care CentersThailandAntifungal AgentsMicafunginempirical dosingICU patientinvasive candidiasisMIC distribution

Identifiers

PMID41164403
PMCPMC12561589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.